Kelsey Ciocia
Physician Assistant · Commack, NYNPI 1801380415
Payments from drug & device makers
Across 91 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$307
- AbbVie$281
- Pfizer$203
- Novartis$180
- Boston Scientific$175
- AstraZeneca$134
- plus $525 from 16 others
What the payments were for
- Food & beverage$1,805100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $307 |
| AbbVie | 13 | $281 |
| Pfizer | 11 | $203 |
| Novartis | 9 | $180 |
| Boston Scientific | 5 | $175 |
| AstraZeneca | 8 | $134 |
| Daiichi Sankyo Inc. | 5 | $104 |
| GSK | 4 | $69 |
| Amgen | 3 | $55 |
| Lilly USA, LLC | 2 | $40 |
| Exact Sciences | 2 | $38 |
| Dexcom, Inc. | 2 | $36 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Johnson & Johnson | 1 | $18 |
| Medtronic | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$1,805 in reported general payments places this provider in the 80th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $22,407 |
| EliquisApixaban | 18 | $21,609 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $10,303 |
| Rosuvastatin Calcium | 92 | $1,644 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $1,383 |
| Levothyroxine Sodium | 63 | $1,086 |
| Atorvastatin Calcium | 87 | $933 |
| Metoprolol Succinate | 49 | $862 |
| Bupropion XlBupropion Hcl | 16 | $853 |
| Duloxetine Hcl | 21 | $834 |
| Azelastine Hcl | 27 | $806 |
| Methylprednisolone | 86 | $617 |
| Metformin Hcl ErMetformin Hcl | 28 | $571 |
| Losartan Potassium | 61 | $549 |
| Omeprazole | 45 | $506 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $307 | $22,40719 claims |
| PfizerEliquis | $203 | $21,60918 claims |
| GSKTrelegy Ellipta | $69 | $10,30311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Commack
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.